Cidara Therapeutics Inc (CDTX)
11.81
-0.17
(-1.42%)
USD |
NASDAQ |
May 01, 16:00
11.77
-0.04
(-0.34%)
Pre-Market: 20:00
Cidara Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
December 29, 2023 | 8.933 |
December 28, 2023 | 9.113 |
December 27, 2023 | 8.978 |
December 26, 2023 | 8.719 |
December 22, 2023 | 9.226 |
December 21, 2023 | 8.302 |
December 20, 2023 | 8.438 |
December 19, 2023 | 8.101 |
December 18, 2023 | 8.247 |
December 15, 2023 | 8.05 |
December 14, 2023 | 8.380 |
December 13, 2023 | 8.078 |
December 12, 2023 | 8.044 |
December 11, 2023 | 8.399 |
December 08, 2023 | 8.324 |
December 07, 2023 | 8.339 |
December 06, 2023 | 8.539 |
December 05, 2023 | 8.776 |
December 04, 2023 | 8.59 |
December 01, 2023 | 8.786 |
November 30, 2023 | 7.981 |
November 29, 2023 | 7.774 |
November 28, 2023 | 7.673 |
November 27, 2023 | 7.910 |
November 24, 2023 | 7.988 |
Date | Value |
---|---|
November 22, 2023 | 8.044 |
November 21, 2023 | 8.241 |
November 20, 2023 | 8.427 |
November 17, 2023 | 8.776 |
November 16, 2023 | 9.033 |
November 15, 2023 | 8.719 |
November 14, 2023 | 8.888 |
November 13, 2023 | 8.776 |
November 10, 2023 | 8.663 |
November 09, 2023 | 8.472 |
November 08, 2023 | 8.776 |
November 07, 2023 | 9.002 |
November 06, 2023 | 9.001 |
November 03, 2023 | 9.113 |
November 02, 2023 | 9.729 |
November 01, 2023 | 9.04 |
October 31, 2023 | 8.629 |
October 30, 2023 | 8.594 |
October 27, 2023 | 8.729 |
October 26, 2023 | 9.094 |
October 25, 2023 | 9.336 |
October 24, 2023 | 9.505 |
October 23, 2023 | 9.461 |
October 20, 2023 | 9.629 |
October 19, 2023 | 9.847 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.905
Minimum
Jun 05 2019
68.91
Maximum
Apr 01 2021
7.792
Average
4.026
Median
Price to Book Value Benchmarks
Johnson & Johnson | 5.196 |
NovaBay Pharmaceuticals Inc | 1.977 |
Palatin Technologies Inc | -- |
iBio Inc | 0.7009 |
Theriva Biologics Inc | 0.1884 |
Price to Book Value Related Metrics
PS Ratio | 0.8596 |
Price | 11.81 |
Earnings Yield | -44.03% |
Market Cap | 53.87M |